Abstract |
Among the various enzymes, reductases that catalyze one-electron reduction are involved in the selective activation of functional compounds or materials in hypoxia, which is one of the well-known pathophysiological characteristics of solid tumors. Enzymatic one-electron reduction has been recognized as a useful reaction that can be applied in the design of tumor hypoxia-targeting drugs. In this report, we characterized the enzymatic reaction of 5-fluorodeoxyuridine (FdUrd) prodrug bearing an indolequinone unit (IQ-FdUrd), which is a substrate of reductases. IQ-FdUrd was activated to release FdUrd under hypoxic conditions after treatment with cytochrome NADPH P450 reductase. We also confirmed that IQ-FdUrd showed selective cytotoxicity in hypoxic tumor cells.
|
Authors | Yota Jiho, Ryohsuke Kurihara, Kiyohiko Kawai, Hisatsugu Yamada, Yoshihiro Uto, Kazuhito Tanabe |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 29
Issue 11
Pg. 1304-1307
(06 01 2019)
ISSN: 1464-3405 [Electronic] England |
PMID | 30975626
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019. Published by Elsevier Ltd. |
Chemical References |
- Indolequinones
- Prodrugs
- Floxuridine
- NADP
- NADPH-Ferrihemoprotein Reductase
|
Topics |
- Cell Hypoxia
(drug effects)
- Dose-Response Relationship, Drug
- Enzyme Activation
- Floxuridine
(chemistry, metabolism, pharmacology)
- Humans
- Indolequinones
(chemistry, metabolism, pharmacology)
- Molecular Structure
- NADP
(metabolism)
- NADPH-Ferrihemoprotein Reductase
(metabolism)
- Prodrugs
(chemistry, metabolism, pharmacology)
- Structure-Activity Relationship
|